Welcome to the 2017 edition of the EUROGIN congress!
Holding the EUROGIN conference this year in Amsterdam delights us for several reasons. For thirty yearsThe Netherlands have been at the forefront of research on HPV and associated cancers. Among the pioneers in HPV research, the very dynamic Dutch teams have made major and continuing scientific contributions to early detection, prevention and basic research. It is also one of the first countries in the world that has implemented a comprehensive national HPV screening program. The robust scientific evidence provided by these teams confirms the cost effectiveness of risk-based screening and paves the way for the development of new strategies for the prevention of HPV-induced cancers. We are proud to highlight this scientific vitality and to pay tribute to this historic turning point which they brought.
The training program of this year’s conference is particularly rich with interesting options for all ...
Laboratories involved in the renewed population screening for cervical cancer in the Netherlands
Five screening laboratories are involved in the Dutch screening program. They are involved in the logistics and perform the HPV-testing and the triage cytology. Interested to hear more about these processes and visit the locations? Sign up here. Registration is based on order of entry.
October 10th - 16.00 – 20.00 - following session SS07
To participate in the excursion, you need to book your seat!
Sign up here